Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Core Viewpoint - Co-Diagnostics, Inc. is set to release its first quarter 2025 financial results on May 8, 2025, and will host a conference call to discuss these results with analysts [1]. Group 1: Financial Results Announcement - The financial results will be released after market close on May 8, 2025 [1]. - A conference call and webcast will take place on the same day at 4:30 p.m. ET [1]. - Key management participating in the call includes the CEO, CFO, and Head of Investor Relations [1]. Group 2: Conference Call Details - The conference call can be accessed via a toll-free number or a toll number, with a participant passcode provided [2]. - A recording of the call will be made available on the company's website for those unable to attend the live session [2]. Group 3: Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company based in Utah, specializing in the development and marketing of advanced diagnostic technologies [3]. - The company's technologies focus on the detection and analysis of nucleic acid molecules, including DNA and RNA [3]. - Co-Diagnostics also utilizes proprietary technology for specific tests related to its Co-Dx PCR at-home and point-of-care platform, as well as for identifying genetic markers for various applications [3].